Denali Therapeutics (DNLI) Selling, General & Administrative (2017 - 2026)
Denali Therapeutics (DNLI) recorded Selling, General & Administrative of $36.28 million in Q2 2026, up 12.4% from $32.27 million a year earlier and up 8.3% from the prior quarter.
Powered by 
Analysis
Denali Therapeutics (DNLI) Selling, General & Administrative (2017 - 2026) Analysis & Trends
On a TTM basis, Denali Therapeutics' Selling, General & Administrative came in at $144.74 million as of Jun 30, 2026, up 24.1% year-over-year; for FY2025, it came in at $136.56 million, up 29.5% from FY2024.
- Annual Selling, General & Administrative has increased for nine straight years, with a five-year compound annual growth rate of 17.8% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $105.44 million in FY2024 (+2.0%), $103.35 million in FY2023 (+14.2%), $90.48 million in FY2022 (+14.4%) and $79.06 million in FY2021 (+31.1%).
- Quarterly Selling, General & Administrative has ranged from $19.32 million in Q3 2021 to $39.46 million in Q4 2025 over the past five years.
- On a year-over-year basis, Selling, General & Administrative has increased for seven consecutive quarters, with growth averaging 20.5% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 42.2% in Q3 2025, against a decline of 7.0% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $33.51 million (Q1 2026), $39.46 million (Q4 2025) and $35.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Denali Therapeutics | 3.28 Bn | 3.28 Bn | 3.51 Mn | 36.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.28 Mn |
| Mar 31, 2026 | 33.51 Mn |
| Dec 31, 2025 | 39.46 Mn |
| Sep 30, 2025 | 35.48 Mn |
| Jun 30, 2025 | 32.27 Mn |
| Mar 31, 2025 | 29.35 Mn |
| Dec 31, 2024 | 30.06 Mn |
| Sep 30, 2024 | 24.95 Mn |
| Jun 30, 2024 | 25.19 Mn |
| Mar 31, 2024 | 25.24 Mn |
| Dec 31, 2023 | 24.77 Mn |
| Sep 30, 2023 | 25.33 Mn |
| Jun 30, 2023 | 26.12 Mn |
| Mar 31, 2023 | 27.14 Mn |
| Dec 31, 2022 | 23.52 Mn |
| Sep 30, 2022 | 23.26 Mn |
| Jun 30, 2022 | 21.16 Mn |
| Mar 31, 2022 | 22.54 Mn |
| Dec 31, 2021 | 21.76 Mn |
| Sep 30, 2021 | 19.32 Mn |
API Access
Denali Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();